Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

Micro-Tech Files for an IPO on the STAR Market Amid Patent Allegations
Micro-Tech Files for an IPO on the STAR Market Amid Patent Allegations
Associated Company
EqualOcean EqualOcean

Micro-Tech, medical devices and equipment developer from Nanjing, will be amongst the first group of the companies that are going to be publicly traded on the STAR Market.

The biopsy needle producer's prospectus brought about two significant concerns that might seriously hurt the investors who will venture into its stocks: the company's ongoing patent lawsuits and stingy R&D expenses. 

As a medical device producer, the company has not given significant weight on research and development in the last three years, Micro-Tech spent around 4.29% of its revenues to R&D in 2016, 5.91% in 2017, and 5.32% in 2018 by a slight decline. 

R&D figures of the company are way behind of its STAR market peers as well. SinoMed (赛诺医疗), a Tianjin-based coronary stent developer, accounted for 17.4% of its revenues for R&D expenses in 2018. Notably, global Medtech heavyweights Medtronic, Siemens and Philips respectively spent 7.5%, 9.2% and 12.7% of their incomes for the research and development expenses in 2017. 

The other primary concern for the investors is Micro-Tech's ongoing patent cases with two firms. If the company found to have infringed the patent rights, it would be fined between CNY 25 million to CNY 43 million, that is about 12% to 22% of its Net Profit's in 2018; the prospectus revealed.

The case is a timing bomb that has yet to explode for the company's future shareholders.

The biopsy needle producer has a stable market within the mainland, considering 10% of the adult population diagnosed with gastrointestinal conditions in 2018, Kantar Health reported.

Biopsy needles are disposable mass-produced goods that have low barriers to entry. Micro-Tech's logistical capacity, cost-effectiveness and delivery network will be the significant indicators to keep tabs on for the company's long term prospects.

Enterprise Information

EqualOcean is a leading industry tech media and an investment research company.
CATEGORIES: AI, Research
Last Funding Type
Series C
Number of Employees
200
Number of Funding Rounds
6
Total Funding Amount
26.79M

Enterprise Information

EqualOcean
EqualOcean is a leading industry tech media and an investment research company.
CATEGORIES: AI, Research
Last Funding Type
Series C
Number of Employees
200
Number of Funding Rounds
6
Total Funding Amount
26.79M

Reach the Author!

Ask the author questions about the copied text

MOST READ

THE LATEST

Any Question

EqualOcean is a leading industrial tech media and investment research company that focuses on technological and industrial innovation in China.

We aim to assist Chinese entrepreneurial enterprises to break into the global market and provide overseas investors, VCs, and enterprises with a deeper understanding of China's business environment and to seize opportunities in China.

Join over 800,000 of your peers